These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31422030)

  • 1. Association between sarcopenia and hepatic encephalopathy: A systematic review and meta-analysis.
    Wijarnpreecha K; Werlang M; Panjawatanan P; Kroner PT; Cheungpasitporn W; Lukens FJ; Pungpapong S; Ungprasert P
    Ann Hepatol; 2020; 19(3):245-250. PubMed ID: 31422030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between sarcopenia and hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: a systematic review and meta-analysis.
    Li Y; Guo Y; Wang X; Gao L
    Abdom Radiol (NY); 2024 Feb; 49(2):575-585. PubMed ID: 37980601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is sarcopenia associated with hepatic encephalopathy in liver cirrhosis? A systematic review and meta-analysis.
    Chang KV; Chen JD; Wu WT; Huang KC; Lin HY; Han DS
    J Formos Med Assoc; 2019 Apr; 118(4):833-842. PubMed ID: 30279030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic Encephalopathy and Nutrition Influences: A Narrative Review.
    Fallahzadeh MA; Rahimi RS
    Nutr Clin Pract; 2020 Feb; 35(1):36-48. PubMed ID: 31872484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Helicobacter pylori with the Risk of Hepatic Encephalopathy.
    Wijarnpreecha K; Chesdachai S; Thongprayoon C; Jaruvongvanich V; Ungprasert P; Cheungpasitporn W
    Dig Dis Sci; 2017 Dec; 62(12):3614-3621. PubMed ID: 29119412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcopenia and risk of nonalcoholic fatty liver disease: A meta-analysis.
    Wijarnpreecha K; Panjawatanan P; Thongprayoon C; Jaruvongvanich V; Ungprasert P
    Saudi J Gastroenterol; 2018; 24(1):12-17. PubMed ID: 29451179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis.
    Bhanji RA; Moctezuma-Velazquez C; Duarte-Rojo A; Ebadi M; Ghosh S; Rose C; Montano-Loza AJ
    Hepatol Int; 2018 Jul; 12(4):377-386. PubMed ID: 29881992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic Encephalopathy in Cirrhotic Patients and Risk of Small Intestinal Bacterial Overgrowth: A Systematic Review and Meta-Analysis.
    Feng X; Li X; Zhang X; Chen W; Tian Y; Yang Q; Yang Y; Pan H; Jiang Z
    Biomed Res Int; 2022; 2022():2469513. PubMed ID: 36303585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hepatic encephalopathy in patients with non-cirrhotic portal hypertension: A systematic review and meta-analysis.
    Giri S; Singh A; Angadi S; Kolhe K; Roy A
    Indian J Gastroenterol; 2023 Oct; 42(5):642-650. PubMed ID: 37589913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of proton pump inhibitors with risk of hepatic encephalopathy in advanced liver disease: A meta-analysis.
    Tantai XX; Yang LB; Wei ZC; Xiao CL; Chen LR; Wang JH; Liu N
    World J Gastroenterol; 2019 Jun; 25(21):2683-2698. PubMed ID: 31210719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcopenia Is Risk Factor for Development of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Placement.
    Nardelli S; Lattanzi B; Torrisi S; Greco F; Farcomeni A; Gioia S; Merli M; Riggio O
    Clin Gastroenterol Hepatol; 2017 Jun; 15(6):934-936. PubMed ID: 27816756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The additive value of sarcopenia, myosteatosis and hepatic encephalopathy in the predictivity of model for end-stage liver disease.
    Lattanzi B; Nardelli S; Pigliacelli A; Di Cola S; Farcomeni A; D'Ambrosio D; Gioia S; Ginanni Corradini S; Lucidi C; Mennini G; Rossi M; Merli M; Riggio O
    Dig Liver Dis; 2019 Nov; 51(11):1508-1512. PubMed ID: 31601536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton pump inhibitor use increases hepatic encephalopathy risk: A systematic review and meta-analysis.
    Ma YJ; Cao ZX; Li Y; Feng SY
    World J Gastroenterol; 2019 Jun; 25(21):2675-2682. PubMed ID: 31210718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of skeletal muscle mass affects the incidence of minimal hepatic encephalopathy: a case control study.
    Tateyama M; Naoe H; Tanaka M; Tanaka K; Narahara S; Tokunaga T; Kawasaki T; Yoshimaru Y; Nagaoka K; Watanabe T; Setoyama H; Sasaki Y; Tanaka Y
    BMC Gastroenterol; 2020 Nov; 20(1):371. PubMed ID: 33167879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis.
    Ampuero J; Simón M; Montoliú C; Jover R; Serra MÁ; Córdoba J; Romero-Gómez M
    Gastroenterology; 2015 Nov; 149(6):1483-9. PubMed ID: 26299413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of and associated factors for sarcopenia in patients with liver cirrhosis: A systematic review and meta-analysis.
    Tuo S; Yeo YH; Chang R; Wen Z; Ran Q; Yang L; Fan Q; Kang J; Si J; Liu Y; Shi H; Li Y; Yuan J; Liu N; Dai S; Guo X; Wang J; Ji F; Tantai X
    Clin Nutr; 2024 Jan; 43(1):84-94. PubMed ID: 38016243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Branched-chain amino acids for people with hepatic encephalopathy.
    Gluud LL; Dam G; Les I; Marchesini G; Borre M; Aagaard NK; Vilstrup H
    Cochrane Database Syst Rev; 2017 May; 5(5):CD001939. PubMed ID: 28518283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detecting minimal hepatic encephalopathy in an endemic country for hepatitis B: the role of psychometrics and serum IL-6.
    Tsai CF; Chu CJ; Huang YH; Wang YP; Liu PY; Lin HC; Lee FY; Lu CL
    PLoS One; 2015; 10(6):e0128437. PubMed ID: 26039496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Branched-chain amino acids for people with hepatic encephalopathy.
    Gluud LL; Dam G; Les I; Córdoba J; Marchesini G; Borre M; Aagaard NK; Vilstrup H
    Cochrane Database Syst Rev; 2015 Sep; (9):CD001939. PubMed ID: 26377410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Branched-chain amino acids for people with hepatic encephalopathy.
    Gluud LL; Dam G; Les I; Córdoba J; Marchesini G; Borre M; Aagaard NK; Vilstrup H
    Cochrane Database Syst Rev; 2015 Feb; (2):CD001939. PubMed ID: 25715177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.